Modified culture method detects a high diversity of fungal species in cystic fibrosis patients.

Cystic fibrosis (CF) is one of the most common genetic lung diseases worldwide. The production of sticky viscous mucus leads to enhanced bacterial colonization and infection, but yeasts and filamentous fungi are also found abundantly in the mucus of patients suffering from CF. The role of fungi in the airways of CF patients is still not understood completely. Furthermore, recent investigations have shown that the spectrum of fungi isolated from the airways of CF patients depends strongly on the methods used. In this study, different mycological culture methods were compared: culture with a native inoculum, culture with homogenization of CF sputum, and culture after homogenization and serial dilutions of CF sputum. Altogether, 934 sputum samples from 113 patients were examined from July 2009 through December 2011. A total of 1,744 fungal isolates was recovered; 20 different yeasts and 14 filamentous fungal species were identified. Candida albicans, C. dubliniensis, and C. parapsilosis were the most common species of yeast. For the filamentous fungi, Aspergillus fumigatus was the most common, followed by Scedosporium apiospermum/Pseudallescheria boydii group and A. terreus. Many fungal, species such as Exophiala dermatitidis, Rasamsonia (Geosmithia) argillacea, and others, were isolated only from homogenized sputum samples. The longitudinal data also show that fungal colonization of CF patients is quite stable, even when treated with itraconazole. In conclusion, we recommend homogenizing CF sputa with a mucolyticum, to prepare serial dilutions, and to use appropriate fungal culture media with added antibiotics.

[1]  N. Güler,et al.  Frequency of fungi in respiratory samples from Turkish cystic fibrosis patients , 2013, Mycoses.

[2]  P. Le Pape,et al.  High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis. , 2012, The Journal of antimicrobial chemotherapy.

[3]  M. Asslaber,et al.  Disseminated Geosmithia argillacea infection in a patient with gastrointestinal GvHD , 2012, Bone Marrow Transplantation.

[4]  S. Leroy,et al.  The Airway Microbiota in Cystic Fibrosis: A Complex Fungal and Bacterial Community—Implications for Therapeutic Management , 2012, PloS one.

[5]  P. Burgel,et al.  High Prevalence of Azole-Resistant Aspergillus fumigatus in Adults with Cystic Fibrosis Exposed to Itraconazole , 2011, Antimicrobial Agents and Chemotherapy.

[6]  R. Siekmeier,et al.  Detection of hyphomycetes in the upper respiratory tract of patients with cystic fibrosis , 2011, Mycoses.

[7]  J. Frisvad,et al.  Rasamsonia, a new genus comprising thermotolerant and thermophilic Talaromyces and Geosmithia species , 2011, Antonie van Leeuwenhoek.

[8]  C. Brightling,et al.  Routine processing procedures for isolating filamentous fungi from respiratory sputum samples may underestimate fungal prevalence , 2011, Medical mycology.

[9]  M. Skov,et al.  Aspergillus Species and Other Molds in Respiratory Samples from Patients with Cystic Fibrosis: a Laboratory-Based Study with Focus on Aspergillus fumigatus Azole Resistance , 2011, Journal of Clinical Microbiology.

[10]  C. Wennerås,et al.  High Rate of Exophiala dermatitidis Recovery in the Airways of Patients with Cystic Fibrosis Is Associated with Pancreatic Insufficiency , 2011, Journal of Clinical Microbiology.

[11]  N. McElvaney,et al.  Candida species in cystic fibrosis: A road less travelled. , 2010, Medical mycology.

[12]  P. Lebecque,et al.  Exophiala (Wangiella) dermatitidis and cystic fibrosis - Prevalence and risk factors. , 2010, Medical mycology.

[13]  S. Ranque,et al.  Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi. , 2010, Medical mycology.

[14]  L. Delhaes,et al.  Fungal respiratory infections in cystic fibrosis: a growing problem. , 2010, Medical mycology.

[15]  F. Müller,et al.  Characteristics of pathogenic fungi and antifungal therapy in cystic fibrosis , 2010, Expert review of anti-infective therapy.

[16]  L. Mély,et al.  Geosmithia argillacea: an Emerging Pathogen in Patients with Cystic Fibrosis , 2010, Journal of Clinical Microbiology.

[17]  J. Houbraken,et al.  Isolation of the Fungus Geosmithia argillacea in Sputum of People with Cystic Fibrosis , 2010, Journal of Clinical Microbiology.

[18]  J. Lipuma.  The Changing Microbial Epidemiology in Cystic Fibrosis , 2010, Clinical Microbiology Reviews.

[19]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.

[20]  P. Flume,et al.  The clinical approach to lung disease in patients with cystic fibrosis. , 2009, Seminars in respiratory and critical care medicine.

[21]  L. Delhaes,et al.  Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis--a review. , 2009, Medical mycology.

[22]  R. Summerbell,et al.  Efficacy of a selective isolation procedure for members of the Pseudallescheria boydii complex , 2008, Antonie van Leeuwenhoek.

[23]  J. Elborn,et al.  Emergence of Scedosporium apiospermum in patients with cystic fibrosis , 2007, Archives of Disease in Childhood.

[24]  F. Accurso.  Update in cystic fibrosis 2006. , 2007, American journal of respiratory and critical care medicine.

[25]  F. Accurso.  Update in cystic fibrosis 2005. , 2006, American journal of respiratory and critical care medicine.

[26]  M. B. de Almeida,et al.  Allergic bronchopulmonary aspergillosis in paediatric cystic fibrosis patients. , 2006, Paediatric respiratory reviews.

[27]  N. Schnitzler,et al.  Isolation of Fungi, Especially Exophiala dermatitidis, in Patients Suffering from Cystic Fibrosis , 2004, Respiration.

[28]  H. Stammberger,et al.  Fungal biodiversity--as found in nasal mucus. , 2003, Medical mycology.

[29]  R. Cornwell,et al.  Aspergillus infection in lung transplant recipients with cystic fibrosis: risk factors and outcomes comparison to other types of transplant recipients. , 2003, Chest.

[30]  Gerald B. Pier,et al.  Lung Infections Associated with Cystic Fibrosis , 2002, Clinical Microbiology Reviews.

[31]  D. Sherris,et al.  The diagnosis and incidence of allergic fungal sinusitis. , 1999, Mayo Clinic proceedings.

[32]  G. Haase,et al.  Exophiala dermatitidis pneumonia in cystic fibrosis , 1992, European Journal of Pediatrics.

[33]  G. Haase,et al.  Exophiala dermatitidis infection in cystic fibrosis , 1990, The Lancet.

[34]  T. Dolan.  Update: cystic fibrosis. , 1986, Pediatric annals.

[35]  L. Montes,et al.  Oral Candidiasis , 1978, Journal of cutaneous pathology.

[36]  H. Elphick,et al.  Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis. , 2014, The Cochrane database of systematic reviews.

[37]  J. Elborn,et al.  Comparison of techniques to examine the diversity of fungi in adult patients with cystic fibrosis. , 2010, Medical mycology.

[38]  T. White.  Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics , 1990 .